New gel shows promise for rosacea redness in small study
NCT ID NCT07431476
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a gel containing brimonidine to see if it can reduce persistent facial redness in people with rosacea. In the first part, 45 adults applied the gel to one side of their face and a placebo to the other, measuring redness after a few hours. In the second part, they used the gel on both sides daily for one month. Redness was measured with a skin color device, magnified images, and patient reports.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
brimonidine gel
What this could lead to
If it works, this could offer a reliable topical option to reduce persistent facial redness in people with rosacea.
What could go wrong
This is a small, completed Phase 4 study with only 45 participants. Results may not apply to all rosacea types, and long-term safety beyond one month is not assessed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ROSACEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istanbul Training and Research Hospital, Department of Dermatology
Istanbul, 34098, Turkey (Türkiye)